Oruka Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -14.4% | -14.4% | -14.1% |
| FY2024 | -21.9% | -21.9% | -21.1% |
| FY2025 | -22.3% | -22.3% | -21.6% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -14.4% | -14.4% | -14.1% |
| FY2024 | -21.9% | -21.9% | -21.1% |
| FY2025 | -22.3% | -22.3% | -21.6% |